ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,424.62
-0.05%
US Tech 100
18,472.40
-0.34%
Dow Jones
39,989.96
0.34%
Brent Oil
79.875
-1.07%
Bitcoin
63,981.09
-2.13%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Fagron NV (FAGR) Quote

Fagron NV

Fagron NV (FAGR)

Wt Agricultu Ld
18.50
-0.12
( -0.64% )
Updated: 09:31:23
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
18.50
Bid
18.46
Ask
18.50
Volume
8,259
18.44 Day's Range 18.62
15.34 52 Week Range 19.06
Market Cap
1.35B
Previous Close
18.62
Open
18.62
Last Trade
30
@
18.5
Last Trade Time
09:31:19
Financial Volume
-
VWAP
-
Average Volume (3m)
45,433
Shares Outstanding
72,987,000
Dividend Yield
-
PE Ratio
19.18
Earnings Per Share (EPS)
0.97
Revenue
766.48M
Net Profit
70.55M

About Fagron NV

Sector
Health & Allied Services,nec
Industry
Health & Allied Services,nec
Website
www.fagron.com
Headquarters
Roermond, Limburg, Nld
Founded
1970
Fagron NV is listed in the Health & Allied Services sector of the Euronext with ticker FAGR. The last closing price for Fagron NV was 18.62 €. Over the last year, Fagron NV shares have traded in a share price range of 15.34 € to 19.06 €.

Fagron NV currently has 72,987,000 shares outstanding. The market capitalization of Fagron NV is 1.36 € billion. Fagron NV has a price to earnings ratio (PE ratio) of 19.18.

FAGR Latest News

More News

Fagron shareholders approve all voting items at AGM and EGM

Fagron shareholders approve all voting items at AGM and EGM Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 13 May 2024 – 7PM CET Fagron shareholders approve all voting...

May 13 2024
GlobeNewswire Inc.

Fagron publishes agenda for 2024 annual shareholders meeting and extraordinary general meeting

Fagron publishes agenda for 2024 annual shareholders meeting and extraordinary general meeting Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 12 April 2024 – 8AM CET...

April 12 2024
GlobeNewswire Inc.

Record revenue of €209 million in first quarter reflecting 15% topline growth

Record revenue of €209 million in first quarter reflecting 15% topline growth Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 11 April 2024 – 7:00 AM...

April 11 2024
GlobeNewswire Inc.

Disclosure notification from Mawer Investment Management Ltd.

Disclosure notification from Mawer Investment Management Ltd. Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 19 March 2024 – 6PM CET Disclosure notification from Mawer...

March 19 2024
GlobeNewswire Inc.

Fagron publishes annual report 2023

Fagron publishes annual report 2023 Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 14 March 2024 – 6:30 PM CET Fagron publishes annual report 2023 Fagron, the leading...

March 14 2024
GlobeNewswire Inc.

Fagron delivers strong performance with 12% topline growth and 14% increase in REBITDA for FY 2023

Fagron delivers strong performance with 12% topline growth and 14% increase in REBITDA for FY 2023 Regulated information – inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 15...

February 15 2024
GlobeNewswire Inc.

Disclosure notification from AOC Pharma S.à r.l. – passing 10% threshold

Disclosure notification from AOC Pharma S.à r.l. – passing 10% threshold Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 8 January 2024 – 8AM CET Disclosure notification...

January 08 2024
GlobeNewswire Inc.

Disclosure of notification received from BNP Paribas Asset Management SA

Disclosure of notification received from BNP Paribas Asset Management SA Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 11 December 2023 – 6PM CET Disclosure of...

December 11 2023
GlobeNewswire Inc.

Disclosure of notification received from BNP Paribas Asset Management SA

Disclosure of notification received from BNP Paribas Asset Management SA Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 9 November 2023 – 6PM CET Disclosure of...

November 09 2023
GlobeNewswire Inc.

Continued strong third quarter performance with 11% topline growth to €191 million

Continued strong third quarter performance with 11% topline growth to €191 million Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 12 October 2023 –...

October 12 2023
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.18-0.96359743040718.6818.918.443647818.74514485DE
40.764.2841037204117.7418.917.723835718.36179513DE
120.160.87241003271518.3419.0617.384543318.4245133DE
261.7710.579796772316.7319.0616.545197617.90014112DE
522.3214.338689740416.1819.0615.345411717.2233977DE
1560.884.994324631117.6219.0610.88694315.50329324DE
2603.5523.74581939814.9523.2610.810748117.13701233DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PBMPsyence Biomedical Ltd
$ 1.09
(178.49%)
32.5M
POAIPredictive Oncology Inc
$ 2.09
(95.33%)
37.3M
BLMZBloomZ Inc
$ 3.46
(41.22%)
3.98M
SLRXSalarius Pharmaceuticals Inc
$ 2.9195
(36.43%)
75.87k
TIVCTivic Health Systems Inc
$ 0.4112
(34.38%)
41.46M
TWOU2U Inc
$ 1.27
(-69.17%)
832.78k
EZFLEzFill Holdings Inc
$ 4.26
(-31.57%)
6.59k
MXLMaxLinear Inc
$ 15.88
(-28.76%)
514.78k
QXOQXO Inc
$ 93.39
(-24.66%)
5.31k
GLYCGlycoMimetics Inc
$ 0.23985
(-22.70%)
1.78M
TIVCTivic Health Systems Inc
$ 0.4112
(34.38%)
41.46M
POAIPredictive Oncology Inc
$ 2.09
(95.33%)
37.3M
STSSSharps Technology Inc
$ 0.2956
(24.57%)
36.06M
PBMPsyence Biomedical Ltd
$ 1.09
(178.49%)
32.5M
CEROCERo Therapeutics Holdings Inc
$ 0.237
(12.32%)
27.92M

Discussion

View Full Feed
StayHumble StayHumble 5 minutes ago
w0w CE0 Kevin Lamb T0P 10 Healthcare innovators🟩F0rbes 0n DECK Huzzah! 0h B0Y $UBQU
https://x.com/CorporateUbqu/status/1802724359762506049


https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
UBQU
wadegarret wadegarret 5 minutes ago
Updated

GERN 25000 shares

IART 3400 shares

HALO 2500 shares

cash $1058
GERN IART
Iggy_Bot Iggy_Bot 5 minutes ago
Anyone know if e*trd and or Ameritrade will let you buy on line ? thanks...
WNFT
CaptainObvious CaptainObvious 5 minutes ago
Friday after hours seems likely
NWBO
SCAMBUSTERKING SCAMBUSTERKING 5 minutes ago
Lifelong scammer. The issue this time is I have no reason to stop making sure he sees jailtime. I wasn't scammed, I am not part of any lawsuit. Reporting crimes to the government isnt a crime. I'm untouchable and have no reason to stop. 🤣
BCAP
PEACHMAN PEACHMAN 5 minutes ago
That would be hype and hope about IFUS which as you know is not a strategy LOL

IFUS shareholders expect extremely positive results from new current testing by both LSU and Southern University for one simple reason.


IFUS scientists know why and how the Science
IFUS
ysung ysung 6 minutes ago
Weeeeee going down scam 😝😝
SPZI
Penny chatter Penny chatter 6 minutes ago
Clowns working overtime solid news and company
STSS
Stockexpertpro Stockexpertpro 6 minutes ago
TWOU Tiny Float in with BRKA
BRKA TWOU
snow snow 6 minutes ago
RD "but it's not a good offer considering the book value of ITUP". I see your point of view. But shareholders of ITUP have the option to keep their shares until they start trading on a major stock exchange. By the way, the reduction of the value of the tokens in SIRI and RISO by almost 70% reduces m
ITUP SIRI
Rainer Rainer 6 minutes ago
ASII - https://finance.yahoo.com/news/accredited-solutions-inc-ceo-issues-120000538.html
ASII
peanutz peanutz 6 minutes ago
This is ready to run again ! Planets aligning here. You know the audit was a real pain in the a$$. Got it done . When S-1 signed and sealed 1 cent coming fast !
RONN
Stockexpertpro Stockexpertpro 6 minutes ago
TWOU Tiny Float in with BRKA
BRKA TWOU
Eagle1 Eagle1 6 minutes ago
Healthy pullback before earnings Aug 28
NVDA
Chartmaster Chartmaster 6 minutes ago
What Cha Waitin 4?
SMCE
chompers chompers 7 minutes ago
Jumped back in at 4 bucks
CMAX
stockstobuy stockstobuy 7 minutes ago
Not a single news of this company is to be believed. They might as well all get tongue cancer for lying too much.
NSAV
Skah373 Skah373 7 minutes ago
I bet elite is making a deal with purdue to make oxy for their authorized supplier, coupled with exclusivity
ELTP
show_me_money show_me_money 7 minutes ago
Filled .0018 first thing this morning.
RONN
IronChefQuezon IronChefQuezon 7 minutes ago
Wait until you hear about the White Sox lol
APRU
michael702/ michael702/ 7 minutes ago
Are they shooting for NASDAQ in the long run?
HIRU
Gizzer211 Gizzer211 7 minutes ago
Out 0016-0021
RONN
blackhawks blackhawks 7 minutes ago
PsiQuantum picks former South Works site for its quantum computer, planning multibillion-dollar investment

The California company will anchor the new quantum computing campus at the old U.S. Steel South Works site to build the country’s first utility-scale quantum computer.
uranium-pinto-beans uranium-pinto-beans 7 minutes ago
Orchestra BioMed initiated with Buy, $15 target at B. Riley
B. Riley last night initiated coverage of Orchestra BioMed with a Buy rating and $15 price target. Orchestra develops medical devices and positions them for commercialization, which will ultimately be driven by leading medical device

Your Recent History

EU
FAGR
Fagron NV
LSE
AIRF
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved